From the latest in exudative and non-exudative retinal disease to award lectures, EURETINA 2025 is officially on in the City of Lights.
The eyes of the ophthalmology world have shifted to Europe this fall, as Day 1 of the 25th Congress of the European Society of Retina Specialists (EURETINA 2025) comes to a close.
As always, we’re covering all the retinal action here in Paris with our live coverage—freshly baked, of course, like the finest baguette from your neighborhood boulangerie.
And yeah, full spoiler alert: if you thought you’d escape pastry puns from the publisher of CAKE, PIE and COOKIE magazines while we’re reporting from one of the bakery capitals of the world, think again. Expect plenty of pun pain (au chocolat) all weekend long, delivered straight from the oven to your screen.
So without further ado, let’s roll out today’s session highlights:
If you thought neovascular age-related macular degeneration treatment might be getting a little… stale (yeah, we’re doing this), think again. Our first highlight session brings fresh insights into one of ophthalmology’s most dynamic and fast-evolving spaces.
READ MORE: EURETINA 2025: What’s Next in the Neovascular AMD Playbook
With all-star panelists like Profs. Usha Chakravarthy and Pearse Keane (UK), Dr. Arshad Khanani (USA) and more, the session tackled topics from retinal telemedicine to fibrosis and cutting-edge gene therapies. This is one you don’t want to miss.
But it’s not just nAMD getting all the attention these days. New advances in dry AMD and geographic atrophy (GA) are picking up steam, and this is exactly what you’ll read about in our second highlight session of Day 1.
READ MORE: The Slow Burn of Dry AMD at EURETINA 2025
Updates on how beleaguered GA complement inhibitors in Europe are going to turn out (Google says that’s a bakery phrase)? Check. New AREDS supplementation controversy? Check. Assessing risk of progression to GA and understanding the disease in three dimensions? Check. We’ve got the full breakdown waiting for you.
For our industry spotlight, we’re covering the latest from Optomed and their push into oculomics with their latest handheld fundus camera, Lumo. If you’re wondering how AI-powered, accessible screening could fit into your clinic, this is a development worth noting. With its fully modular ecosystem, the future of using the eye to potentially detect a wide variety of diseases could be here now. Check out the article and head on over to booth #3.A68 for the latest on Lumo with the Optomed team.
To round things out, our late-breaking session celebrates some of the best in European retina with the EURETINA 2025 Opening Ceremony and EURETINA keynote lecture.
With a record attendance of over 11,000 registrants, EURETINA President Prof. Anat Loewenstein (Israel) kicked off the Congress’ 25th birthday celebration in style… along with a lecture on artificial intelligence by a certain titan of European ophthalmology and the announcement of several other accolades, including the 2025 Professor Ramin Tadayoni Award. For the full scoop, read the article now.
Well, I’m fresh out of baking puns (and content to promote) so that about wraps it up for Day 1 here in Paris. See you for our EURETINA Day 2—so stay tuned.
Editor’s Note: The 25th EURETINA Congress is being held from 4-7 September, in Paris, France. Reporting for this story took place during the event. This content is intended exclusively for healthcare professionals. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.